Abstract
No head-to-head studies exist comparing BRAF inhibitor/MEK inhibitor (BRAFi/MEKi) combination treatments for BRAF-mutant melanoma. A side-by-side anal......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
